Advertisement

World Journal of Urology

, Volume 30, Issue 3, pp 379–383 | Cite as

Oncologic outcomes following radical prostatectomy with intraoperative cell salvage

  • Michael A. Gorin
  • Ahmed Eldefrawy
  • Murugesan Manoharan
  • Mark S. Soloway
Original Article

Abstract

Purpose

To evaluate oncologic outcomes following the use of intraoperative cell salvage (IOCS) as a blood loss management strategy during open radical prostatectomy (RP).

Methods

We retrospectively reviewed all open retropubic RP cases performed by a single surgeon. Patients were identified who received IOCS blood and evaluated for an increased risk of biochemical recurrence (BCR) and overall mortality.

Results

The study cohort consisted of 1,862 men, 395 (21.2%) of whom received IOCS blood. At a median follow-up of 47.0 months, men who received IOCS blood were not at an increased risk of BCR (P = 0.323) or all-cause mortality (P = 0.892). IOCS use did not confer an increased risk of BCR within any D’Amico preoperative risk category (low risk, P = 0.592; intermediate risk, P = 0.107; and high risk, P = 0.697).

Conclusions

IOCS is safe for the management of blood loss during RP. At long-term follow-up, IOCS use was not associated with an increased risk of BCR or death. While it remains preferable to avoid any form of blood transfusion, we advocate for the use of IOCS in place of allogeneic blood. These conclusions are drawn from our study of the largest and longest followed cohort patients who received IOCS blood during RP.

Keywords

Biochemical recurrence Blood transfusion Intraoperative cell salvage Prostate cancer Radical prostatectomy 

Notes

Acknowledgments

CURED and Vincent A. Rodriguez.

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1.
    Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300PubMedCrossRefGoogle Scholar
  2. 2.
    Cooperberg MR, Broering JM, Kantoff PW, Carroll PR (2007) Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol 178:S14–S19PubMedCrossRefGoogle Scholar
  3. 3.
    Rabbani F, Yunis LH, Pinochet R, Nogueira L, Vora KC, Eastham JA et al (2010) Comprehensive standardized report of complications of retropubic and laparoscopic radical prostatectomy. Eur Urol 57:371–386PubMedCrossRefGoogle Scholar
  4. 4.
    Hu JC, Gu X, Lipsitz SR, Barry MJ, D’Amico AV, Weinberg AC et al (2009) Comparative effectiveness of minimally invasive versus open radical prostatectomy. JAMA 302:1557–1564PubMedCrossRefGoogle Scholar
  5. 5.
    Di Pierro GB, Baumeister P, Stucki P, Beatrice J, Danuser H, Mattei A (2011) A prospective trial comparing consecutive series of open retropubic and robot-assisted laparoscopic radical prostatectomy in a centre with a limited caseload. Eur Urol 59:1–6PubMedCrossRefGoogle Scholar
  6. 6.
    Noldus J, Gonnermann D, Huland H (1995) Autologous blood transfusion in radical prostatectomy: results in 263 patients. Eur Urol 27:213–217PubMedGoogle Scholar
  7. 7.
    Lepor H, Lipkin M, Slova D (2010) The preoperative use of erythropoietin stimulating proteins prior to radical prostatectomy is not associated with increased cardiovascular or thromboembolic morbidity or mortality. Urology 75:1424–1428PubMedCrossRefGoogle Scholar
  8. 8.
    Takayanagi A, Masumori N, Kobayashi K, Kunishima Y, Takahashi A, Itoh N et al (2008) Acute normovolemic hemodilution for radical retropubic prostatectomy and radical cystectomy. Urology 72:401–405PubMedCrossRefGoogle Scholar
  9. 9.
    Gray CL, Amling CL, Polston GR, Powell CR, Kane CJ (2001) Intraoperative cell salvage in radical retropubic prostatectomy. Urology 58:740–745PubMedCrossRefGoogle Scholar
  10. 10.
    Vamvakas EC, Blajchman MA (2009) Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 113:3406–3417PubMedCrossRefGoogle Scholar
  11. 11.
    Davis M, Sofer M, Gomez-Marin O, Bruck D, Soloway MS (2003) The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence? BJU Int 91:474–476PubMedCrossRefGoogle Scholar
  12. 12.
    Nieder AM, Carmack AJ, Sved PD, Kim SS, Manoharan M, Soloway MS (2005) Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate. Urology 65:730–734PubMedCrossRefGoogle Scholar
  13. 13.
    Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D’Amico AV, Dmochowski RR et al (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for localized prostate cancer update panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177:540–545PubMedCrossRefGoogle Scholar
  14. 14.
    D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974PubMedCrossRefGoogle Scholar
  15. 15.
    Klein HG (2010) How safe is blood, really? Biologicals 38:100–104PubMedCrossRefGoogle Scholar
  16. 16.
    Ward JF, Nowacki M, Sands JP, Conner RJ, Huisman TK (1996) Malignant cytological washings from radical prostatectomy specimens: a possible mechanism for local recurrence of prostate cancer following surgical treatment of organ confined disease. J Urol 156:1381–1384PubMedCrossRefGoogle Scholar
  17. 17.
    Ward JF, Sands JP, Nowacki M, Amling CL (2001) Malignant cytological washings from prostate specimens: an independent predictor of biochemical progression after radical prostatectomy. J Urol 165:469–473PubMedCrossRefGoogle Scholar
  18. 18.
    Nieder AM, Manoharan M, Yang Y, Soloway MS (2007) Intraoperative cell salvage during radical cystectomy does not affect long-term survival. Urology 69:881–884PubMedCrossRefGoogle Scholar
  19. 19.
    MacIvor D, Nelson J, Triulzi D (2009) Impact of intraoperative red blood cell salvage on transfusion requirements and outcomes in radical prostatectomy. Transfusion 49:1431–1434PubMedCrossRefGoogle Scholar
  20. 20.
    Valbonesi M, Bruni R, Lercari G, Florio G, Carlier P, Morelli F (1999) Autoapheresis and intraoperative blood salvage in oncologic surgery. Transfus Sci 21:129–139PubMedCrossRefGoogle Scholar
  21. 21.
    Hansen E, Bechmann V, Altmeppen J (2002) Intraoperative blood salvage in cancer surgery: safe and effective? Transfus Apher Sci 27:153–157PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Michael A. Gorin
    • 1
  • Ahmed Eldefrawy
    • 1
  • Murugesan Manoharan
    • 1
  • Mark S. Soloway
    • 1
  1. 1.Department of UrologyUniversity of Miami Miller School of MedicineMiamiUSA

Personalised recommendations